Nanobac Pharmaceuticals (NNBP) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NNBP Stock Alerts Add Compare Share Share Short InterestStock AnalysisChartStock AnalysisChart Nanobac Pharmaceuticals Short Interest DataCurrent Short Volume6,600 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$13.20Short Interest Ratio / Days to Cover0.0Last Record DateMay 14, 2021Today's Trading Volume0 sharesAverage Trading Volume0 sharesToday's Volume Vs. AverageNaN Short Selling Nanobac Pharmaceuticals ? Sign up to receive the latest short interest report for Nanobac Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNNBP Short Interest Over TimeNNBP Days to Cover Over TimeNNBP Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Nanobac Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/14/20216,600 shares $13.20 No ChangeN/A0 $0.00 4/15/2021900 shares $1.44 No ChangeN/A0 $0.00 3/15/202113,000 shares $32.50 No ChangeN/A0 $0.00 11/15/202040,800 shares $36.72 No ChangeN/A0.3 $0.00 NNBP Short Interest - Frequently Asked Questions What is Nanobac Pharmaceuticals' current short interest? Short interest is the volume of Nanobac Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of May 14th, traders have sold 6,600 shares of NNBP short. Learn More on Nanobac Pharmaceuticals' current short interest. Is Nanobac Pharmaceuticals' short interest increasing or decreasing? Nanobac Pharmaceuticals saw a increase in short interest during the month of May. As of May 14th, there was short interest totaling 6,600 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Nanobac Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Nanobac Pharmaceuticals: Context Therapeutics Inc. (0.29%), International Stem Cell Co. (0.00%), LAVA Therapeutics (1.37%), Mainz Biomed (2.30%), NLS Pharmaceutics Ltd. (0.34%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Aon plc ($6.79 billion), Charter Communications, Inc. ($5.98 billion), Analog Devices, Inc. ($5.56 billion), S&P Global Inc. ($5.37 billion), Airbnb, Inc. ($3.72 billion), Nuance Communications, Inc. ($2.87 billion), Snap Inc. ($2.70 billion), Expedia Group, Inc. ($2.27 billion), The Kroger Co. ($2.19 billion), and VMware, Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Nanobac Pharmaceuticals stock? Short selling NNBP is an investing strategy that aims to generate trading profit from Nanobac Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nanobac Pharmaceuticals? A short squeeze for Nanobac Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NNBP, which in turn drives the price of the stock up even further. How often is Nanobac Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NNBP, twice per month. The most recent reporting period available is May, 14 2021. More Short Interest Resources from MarketBeat Related Companies: NEVPF Short Interest AFFY Short Interest ABMC Short Interest ANTH Short Interest BAYRY Short Interest CNTX Short Interest IMUC Short Interest EPRSQ Short Interest GNMSF Short Interest GBIM Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NNBP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press